RU2015140499A - Композиция для применения в лечении синдрома поликистоза яичников - Google Patents

Композиция для применения в лечении синдрома поликистоза яичников Download PDF

Info

Publication number
RU2015140499A
RU2015140499A RU2015140499A RU2015140499A RU2015140499A RU 2015140499 A RU2015140499 A RU 2015140499A RU 2015140499 A RU2015140499 A RU 2015140499A RU 2015140499 A RU2015140499 A RU 2015140499A RU 2015140499 A RU2015140499 A RU 2015140499A
Authority
RU
Russia
Prior art keywords
composition
use according
lipoic acid
monacolin
polycystic ovary
Prior art date
Application number
RU2015140499A
Other languages
English (en)
Russian (ru)
Inventor
Лоренцо СЕКОНДИНИ
Луиджи АМЕЛОТТИ
Original Assignee
Лаборест Италия С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборест Италия С.П.А. filed Critical Лаборест Италия С.П.А.
Publication of RU2015140499A publication Critical patent/RU2015140499A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Materials For Photolithography (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2015140499A 2013-03-07 2014-03-07 Композиция для применения в лечении синдрома поликистоза яичников RU2015140499A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2013A000349 2013-03-07
IT000349A ITMI20130349A1 (it) 2013-03-07 2013-03-07 Composizione per uso nel trattamento della sindrome dell ovaio policistico
PCT/IB2014/000257 WO2014135956A1 (en) 2013-03-07 2014-03-07 Composition for use in the treatment of polycystic ovary syndrome

Publications (1)

Publication Number Publication Date
RU2015140499A true RU2015140499A (ru) 2017-04-12

Family

ID=48579220

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015140499A RU2015140499A (ru) 2013-03-07 2014-03-07 Композиция для применения в лечении синдрома поликистоза яичников

Country Status (5)

Country Link
EP (1) EP2964207A1 (de)
BR (1) BR112015021722A2 (de)
IT (1) ITMI20130349A1 (de)
RU (1) RU2015140499A (de)
WO (1) WO2014135956A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7203521B2 (ja) * 2018-06-29 2023-01-13 小林製薬株式会社 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
MX2021005888A (es) 2018-11-26 2021-06-23 Procter & Gamble Preparacion farmaceutica solida que contiene acido lipoico y uso de esta.
CN109517740B (zh) * 2018-12-05 2020-11-27 广东天益生物科技有限公司 一株紫色红曲霉诱变株和一种水溶性功能红曲及其制备方法和应用
IT201900025063A1 (it) * 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
US11850218B2 (en) * 2022-05-17 2023-12-26 Provation Life LLC Nutraceutical compositions and methods for dietary alleviation of Polycystic Ovary Syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403587B1 (it) * 2010-12-17 2013-10-31 Laborest Italia S P A Composizione per il trattamento di disordini metabolici

Also Published As

Publication number Publication date
BR112015021722A2 (pt) 2017-07-18
WO2014135956A1 (en) 2014-09-12
ITMI20130349A1 (it) 2014-09-08
EP2964207A1 (de) 2016-01-13

Similar Documents

Publication Publication Date Title
RU2015140499A (ru) Композиция для применения в лечении синдрома поликистоза яичников
RU2018114447A (ru) Введение дейтерированных усилителей cftr
RU2019131148A (ru) Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
BR112014028841A2 (pt) processo para preparação de n-[5-(3,5-difluoro-benzil)-1h-indazol-3-il]-4-(4-metil-piperazin-l-il)-2-(tetra-hidro-piran-4-ilamino)-benzamida
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
WO2013066835A3 (en) Compounds and methods
WO2013066839A3 (en) Compounds and methods
EA201391561A1 (ru) Новые соединения-модуляторы gpr-119
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
RU2018135921A (ru) Стабилизированные составы ванкомицина
MD20140072A2 (ro) Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201491362A1 (ru) Анестезирующие соединения и способы их применения
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
EA201391574A1 (ru) Фармацевтически приемлемые сокристаллы n-[2-(7-метокси-1-нафтил)этил]ацетамида и способы их получения
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
EA201891804A1 (ru) Тетрациклиновые соединения
GEP201606598B (en) Heteroaromatic compounds as dopamine d1 ligands
EA201201294A1 (ru) Гидрат гидрохлорида агомелатина и его получение
BR112014003849A2 (pt) projeto de estrutura e componentes de veículo para embalagem eficiente e compacta
WO2011123536A8 (en) Polycyclic tetracycline compounds
CA2899024C (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
RU2013130308A (ru) Композиция для лечения метаболических расстройств
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
EA201600323A1 (ru) Производные пиперазина и их применение в качестве лекарственного средства